- Report
- May 2025
- 95 Pages
Asia Pacific
From €3015EUR$3,450USD£2,634GBP
- Report
- May 2025
- 96 Pages
Europe
From €3015EUR$3,450USD£2,634GBP
- Report
- May 2025
- 87 Pages
North America
From €2578EUR$2,950USD£2,253GBP
- Report
- May 2025
- 230 Pages
United States
From €3496EUR$4,000USD£3,054GBP
- Report
- July 2020
- 269 Pages
Global
From €3056EUR$3,497USD£2,670GBP
- Report
- June 2023
- 150 Pages
Global
From €3492EUR$3,995USD£3,051GBP
- Report
- May 2023
- 250 Pages
Global
From €3492EUR$3,995USD£3,051GBP
- Report
- August 2024
- 80 Pages
Global
From €1311EUR$1,500USD£1,145GBP
- Report
- June 2023
- 56 Pages
Global
€2141EUR$2,450USD£1,871GBP
- Report
- December 2022
- 56 Pages
China
€1394EUR$1,595USD£1,218GBP
- Report
- October 2022
- 220 Pages
Global
From €1660EUR$1,899USD£1,450GBP
- Report
- September 2022
- 799 Pages
Global
From €4194EUR$4,799USD£3,665GBP
- Report
- July 2022
- 197 Pages
Global
From €4194EUR$4,799USD£3,665GBP
- Report
- February 2022
- 305 Pages
Global
From €4194EUR$4,799USD£3,665GBP
- Report
- January 2022
- 294 Pages
Global
From €4194EUR$4,799USD£3,665GBP
- Report
- June 2024
- 299 Pages
Global
From €5153EUR$6,102USD£4,350GBP
- Report
- May 2024
- 391 Pages
Global
From €5153EUR$6,102USD£4,350GBP
- Report
- April 2024
- 364 Pages
Global
From €5153EUR$6,102USD£4,350GBP
- Report
- March 2024
- 239 Pages
Global
From €5153EUR$6,102USD£4,350GBP
- Report
- February 2024
- 270 Pages
Global
From €5153EUR$6,102USD£4,350GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more